MALTA, N.Y., July 06, 2022 (GLOBE NEWSWIRE) — GlobalFoundries (NASDAQ: GFS) today announced that it will host a conference call on Tuesday, August 9, 2022, at 8:30am ET following the release of its second quarter 2022 financial results.
Conference Call and Webcast Information
The company will host a conference call with the financial community on Tuesday, August 9, 2022, at 8:30am ET. Interested parties may join the scheduled conference call by registering here.
The company’s financial results and a webcast of the conference call will be available on GF’s Investor Relations website at https://investors.gf.com.
2022 Capital Markets Day
Following the second quarter financial results on August 9th, GF will host its first Capital Markets Day on August 10, 2022, in New York City. The Capital Markets Day event will include business, manufacturing, technology, and finance updates from GF executives. Additional details, including registration information, for the 2022 Capital Markets Day can be obtained at https://investors.gf.com or by contacting firstname.lastname@example.org.
GlobalFoundries® Inc. (GF®) is one of the world’s leading semiconductor manufacturers. GF is redefining innovation and semiconductor manufacturing by developing and delivering feature-rich process technology solutions that provide leadership performance in pervasive high growth markets. GF offers a unique mix of design, development and fabrication services. With a talented and diverse workforce and an at-scale manufacturing footprint spanning the U.S., Europe and Asia, GF is a trusted technology source to its worldwide customers. For more information, visit www.gf.com.
For further information, please contact:
- ROSEN, A TOP RANKED FIRM, Encourages Missfresh Limited Investors to Secure Counsel Before Important Deadline in First Filed Securities Class Action Initiated by the Firm – MF - August 13, 2022
- ROSEN, A TOP RANKED FIRM, Encourages Wells Fargo & Company Investors to Secure Counsel Before Important August 29 Deadline in Securities Class Action – WFC - August 13, 2022
- Plus Therapeutics Presents Positive Data from Ongoing ReSPECT™ Clinical Trials at the Annual Conference on CNS Clinical Trials and Brain Metastases - August 13, 2022